Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Update

Sunshine Biopharma, Inc. (NASDAQ:SBFM) was the recipient of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 374,100 shares, an increase of 16.4% from the October 15th total of 321,500 shares. Based on an average daily trading volume, of 180,600 shares, the days-to-cover ratio is presently 2.1 days. Approximately 18.7% of the shares of the company are sold short.

Sunshine Biopharma Trading Down 8.8 %

NASDAQ:SBFM traded down $0.22 on Friday, hitting $2.35. The company’s stock had a trading volume of 311,442 shares, compared to its average volume of 128,355. Sunshine Biopharma has a one year low of $2.25 and a one year high of $637.20. The firm has a market capitalization of $2.87 million, a P/E ratio of -0.02 and a beta of 1.38. The stock has a fifty day moving average of $2.92 and a two-hundred day moving average of $1.72.

Sunshine Biopharma (NASDAQ:SBFM) last posted its earnings results on Tuesday, November 5th. The company reported ($0.94) earnings per share for the quarter, missing analysts’ consensus estimates of $9.00 by ($9.94). Sunshine Biopharma had a negative return on equity of 17.89% and a negative net margin of 12.82%. The business had revenue of $8.44 million for the quarter.

Sunshine Biopharma Company Profile

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.